Classification and comparison of ligand-binding sites derived from grid-mapped knowledge-based potentials.
暂无分享,去创建一个
Christoph Steinbeck | C. Steinbeck | Christian Hoppe | G. Wohlfahrt | Christian Hoppe | Gerd Wohlfahrt
[1] M. Karplus,et al. Effective energy functions for protein structure prediction. , 2000, Current opinion in structural biology.
[2] David H. Williams,et al. Latest developments in crystallography and structure-based design of protein kinase inhibitors as drug candidates. , 2002, Current opinion in pharmacology.
[3] Robert P Sheridan,et al. A simple method for visualizing the differences between related receptor sites. , 2002, Journal of molecular graphics & modelling.
[4] D. Tobi,et al. Sequence-based Design of Kinase Inhibitors Applicable for Therapeutics and Target Identification* , 2004, Journal of Biological Chemistry.
[5] Eunsun Lee,et al. Discovery of potent, nonsteroidal, and highly selective glucocorticoid receptor antagonists. , 2002, Journal of medicinal chemistry.
[6] Z. Deng,et al. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. , 2004, Journal of medicinal chemistry.
[7] Giulia Caron,et al. Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction. , 2004, Journal of medicinal chemistry.
[8] A. Tulinsky,et al. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes. , 1998, Biochemistry.
[9] D. Schomburg,et al. BRAGI: a comprehensive protein modeling program system , 1988 .
[10] Alexander Levitzki,et al. Protein kinase inhibitors as a therapeutic modality. , 2003, Accounts of chemical research.
[11] Gerhard Klebe,et al. Understanding protein-ligand interactions: the price of protein flexibility. , 2004, Journal of molecular biology.
[12] S. Pickett,et al. GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. , 2000, Journal of medicinal chemistry.
[13] U. Lessel,et al. Similarities between protein 3-D structures. , 1994, Protein engineering.
[14] J M Thornton,et al. X-SITE: use of empirically derived atomic packing preferences to identify favourable interaction regions in the binding sites of proteins. , 1996, Journal of molecular biology.
[15] James M. Hogle,et al. Functional group placement in protein binding sites: a comparison of GRID and MCSS , 2001, J. Comput. Aided Mol. Des..
[16] Robin Taylor,et al. SuperStar: a knowledge-based approach for identifying interaction sites in proteins. , 1999, Journal of molecular biology.
[17] Qi Sun,et al. Slit Branches Out A Secreted Protein Mediates Both Attractive and Repulsive Axon Guidance , 1999, Cell.
[18] M. A. Carrondo,et al. Structural Basis for the Glucocorticoid Response in a Mutant Human Androgen Receptor (ARccr) Derived from an Androgen-Independent Prostate Cancer , 2002 .
[19] R C Wade,et al. Identifying targets for bioreductive agents: using GRID to predict selective binding regions of proteins. , 1989, Journal of molecular graphics.
[20] Giulia Caron,et al. Docking studies on NSAID/COX-2 isozyme complexes using Contact Statistics analysis , 2004, J. Comput. Aided Mol. Des..
[21] M. Karplus,et al. Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.
[22] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[23] D. Moras,et al. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. , 2002, Molecular cell.
[24] Mika A. Kastenholz,et al. GRID/CPCA: a new computational tool to design selective ligands. , 2000, Journal of medicinal chemistry.
[25] Knut Baumann,et al. Structure-Based Validation of the 3D-QSAR Technique MaP , 2005, J. Chem. Inf. Model..
[26] L. Johnson,et al. Protein Kinase Inhibitors: Insights into Drug Design from Structure , 2004, Science.
[27] Gert Vriend,et al. Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems , 2001, Nucleic Acids Res..
[28] Peter Willett,et al. A bibliometric analysis of the Journal of Molecular Graphics and Modelling. , 2007, Journal of molecular graphics & modelling.
[29] J. Edwards,et al. 5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators. , 2003, Journal of medicinal chemistry.
[30] Robin Taylor,et al. IsoStar: A library of information about nonbonded interactions , 1997, J. Comput. Aided Mol. Des..
[31] M Carlquist,et al. Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.
[32] Peter Scholz,et al. Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor , 2000, The Journal of Biological Chemistry.
[33] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] T. Kaminuma. Pathways and Networks of Nuclear Receptors and Modeling of Syndrome X , 2003 .
[35] M. Berenbaum,et al. Molecular docking of substrates and inhibitors in the catalytic site of CYP6B1, an insect cytochrome p450 monooxygenase. , 2003, Protein Engineering.
[36] Robert P. Sheridan,et al. Calculating Similarities between Biological Activities in the MDL Drug Data Report Database , 2004, J. Chem. Inf. Model..
[37] Bernard Pirard,et al. Peroxisome Proliferator-Activated Receptors target family landscape: A chemometrical approach to ligand selectivity based on protein binding site analysis , 2003, J. Comput. Aided Mol. Des..
[38] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[39] Ettore Novellino,et al. A Critical Review of Recent CoMFA Applications , 1998 .
[40] Ricardo Coelho,et al. Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer. , 2002, Journal of medicinal chemistry.
[41] Antti Poso,et al. BRUTUS: optimization of a grid-based similarity function for rigid-body molecular superposition. 1. Alignment and virtual screening applications. , 2005, Journal of medicinal chemistry.
[42] Jussi Parkkinen,et al. BRUTUS: Optimization of a grid-based similarity function for rigid-body molecular superposition. II. Description and characterization , 2006, J. Comput. Aided Mol. Des..
[43] G L Trainor,et al. Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation. , 2000, Journal of medicinal chemistry.
[44] G. Klebe,et al. DrugScore meets CoMFA: adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein. , 2002, Journal of medicinal chemistry.
[45] Brian K Shoichet,et al. Kinase inhibitors: not just for kinases anymore. , 2003, Journal of medicinal chemistry.
[46] H. Matter,et al. Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes. , 2002, Journal of medicinal chemistry.
[47] Richard Morphy,et al. From magic bullets to designed multiple ligands. , 2004, Drug discovery today.
[48] M Pastor,et al. A novel strategy for improving ligand selectivity in receptor-based drug design. , 1995, Journal of medicinal chemistry.
[49] M. A. Carrondo,et al. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. , 2000, The Journal of biological chemistry.
[50] Peter Wolohan,et al. CoMFA and docking study of novel estrogen receptor subtype selective ligands , 2003, J. Comput. Aided Mol. Des..
[51] M. Verdonk,et al. SuperStar: comparison of CSD and PDB-based interaction fields as a basis for the prediction of protein-ligand interactions. , 2001, Journal of molecular biology.